Published in Am J Pathol on September 01, 1998
Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17
Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34
Molecular basis of metastasis. N Engl J Med (2008) 8.19
Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol (2000) 5.26
Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell (2012) 4.51
Cancer to bone: a fatal attraction. Nat Rev Cancer (2011) 4.08
Real-time imaging reveals the single steps of brain metastasis formation. Nat Med (2009) 3.95
Oxidative stress inhibits distant metastasis by human melanoma cells. Nature (2015) 3.87
A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One (2009) 3.86
Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell (2012) 3.39
Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell (2012) 2.94
Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell (2011) 2.64
Origins of metastatic traits. Cancer Cell (2013) 2.49
Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer (2010) 2.31
Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med (2007) 2.29
The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell (2008) 2.27
E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis (2008) 2.21
Does tumour dormancy offer a therapeutic target? Nat Rev Cancer (2010) 2.19
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis (2014) 2.07
The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res (2005) 1.94
A "class action" against the microenvironment: do cancer cells cooperate in metastasis? Cancer Metastasis Rev (2008) 1.91
Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell (2014) 1.88
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol (2015) 1.87
Mechanisms governing metastatic dormancy and reactivation. Cell (2013) 1.81
The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells. PLoS One (2009) 1.72
Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am J Pathol (2010) 1.68
Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis (2007) 1.68
Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci (2010) 1.67
Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J Clin Invest (2011) 1.65
Strategies for the discovery and development of therapies for metastatic breast cancer. Nat Rev Drug Discov (2012) 1.61
Homeostatic competition drives tumor growth and metastasis nucleation. HFSP J (2009) 1.55
Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma. Br J Ophthalmol (2010) 1.53
ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. Mol Biol Cell (2009) 1.52
Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia (2005) 1.48
Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation. PLoS One (2015) 1.43
The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov (2012) 1.40
Breakdown of the endothelial barrier function in tumor cell transmigration. Biophys J (2007) 1.39
Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer (2015) 1.39
Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol Cell Biol (2001) 1.38
Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron (2008) 1.37
Mechanisms of metastasis. Breast Cancer Res (2008) 1.34
Metastatic colonization by circulating tumour cells. Nature (2016) 1.31
Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis (2007) 1.29
Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res (2000) 1.28
The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. Cell Commun Signal (2010) 1.27
Targeting metastasis. Nat Rev Cancer (2016) 1.26
Clinical opportunities and challenges in targeting tumour dormancy. Nat Rev Clin Oncol (2012) 1.26
Tumour dormancy in breast cancer: an update. Breast Cancer Res (2007) 1.23
Toward a drug development path that targets metastatic progression in osteosarcoma. Clin Cancer Res (2014) 1.23
Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle (2006) 1.21
Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation. Neoplasia (2000) 1.20
Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. Am J Pathol (2001) 1.19
Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy. Cell Cycle (2006) 1.19
GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice. Clin Exp Metastasis (2003) 1.19
Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis. Clin Exp Metastasis (2006) 1.19
Mechanisms of tumor cell extravasation in an in vitro microvascular network platform. Integr Biol (Camb) (2013) 1.19
Hepatic stellate cells: partners in crime for liver metastases? Hepatology (2011) 1.17
Host genetics and tumour metastasis. Br J Cancer (2004) 1.17
Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate. Clin Exp Metastasis (1999) 1.16
The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol (2012) 1.15
A secreted factor represses cell proliferation in Dictyostelium. Development (2005) 1.14
Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front Biosci (Landmark Ed) (2011) 1.12
Tumor-host interactions: the role of inflammation. Histochem Cell Biol (2008) 1.11
Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17. Mamm Genome (2005) 1.10
Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy. Neoplasia (2008) 1.08
The prometastatic microenvironment of the liver. Cancer Microenviron (2008) 1.08
Regulation of cancer metastasis by stress pathways. Clin Exp Metastasis (2003) 1.07
The secreted Dictyostelium protein CfaD is a chalone. J Cell Sci (2008) 1.04
Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? Cancers (Basel) (2010) 1.04
The dormancy dilemma: quiescence versus balanced proliferation. Cancer Res (2013) 1.04
A review of the association between osteosarcoma metastasis and protein translation. J Comp Pathol (2012) 1.04
Decoding melanoma metastasis. Cancers (Basel) (2010) 1.02
Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Breast Cancer Res (2012) 1.02
Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. Am J Pathol (2002) 1.01
Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer Features. Front Oncol (2013) 0.99
Embryonic morphogen nodal promotes breast cancer growth and progression. PLoS One (2012) 0.97
Molecular mechanisms of bone metastasis and associated muscle weakness. Clin Cancer Res (2014) 0.97
Role of the endothelium during tumor cell metastasis: is the endothelium a barrier or a promoter for cell invasion and metastasis? J Biophys (2009) 0.96
Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo. PLoS One (2011) 0.96
Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy. PLoS Comput Biol (2015) 0.96
A 60-kilodalton protein component of the counting factor complex regulates group size in Dictyostelium discoideum. Eukaryot Cell (2006) 0.95
Emerging Biological Principles of Metastasis. Cell (2017) 0.94
BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation. Clin Exp Metastasis (2008) 0.94
Metastasis of tumor cells is enhanced by downregulation of Bit1. PLoS One (2011) 0.94
CTC enumeration and characterization: moving toward personalized medicine. Ann Transl Med (2014) 0.94
Tumour dormancy and clinical implications in breast cancer. Ecancermedicalscience (2013) 0.92
Circulating tumor cells measurements in hepatocellular carcinoma. Int J Hepatol (2012) 0.91
Resistance to fluid shear stress is a conserved biophysical property of malignant cells. PLoS One (2012) 0.91
Distinctive properties of metastasis-initiating cells. Genes Dev (2016) 0.91
Circulating tumor cell enrichment based on physical properties. J Lab Autom (2013) 0.90
Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value. Clin Exp Metastasis (2007) 0.90
Cell density sensing and size determination. Dev Growth Differ (2011) 0.90
Solitary cerebral metastasis from transitional cell carcinoma after a 14-year remission of urinary bladder cancer treated with gemcitabine: Case report and literature review. Surg Neurol Int (2012) 0.90
Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system. Br J Cancer (2014) 0.90
Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity. Front Oncol (2015) 0.90
Metastatic cancer stem cells: from the concept to therapeutics. Am J Stem Cells (2014) 0.89
An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease. Genome Res (2013) 0.89
Dormancy in breast cancer. Breast Cancer (Dove Med Press) (2012) 0.89
Modeling boundary conditions for balanced proliferation in metastatic latency. Clin Cancer Res (2013) 0.89
The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"? Int J Breast Cancer (2011) 0.89
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell (1991) 9.73
Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med (1995) 7.37
Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol (1993) 6.53
The role of angiogenesis in tumor growth. Semin Cancer Biol (1992) 5.33
The circulation of the fetus in utero. Methods for studying distribution of blood flow, cardiac output and organ blood flow. Circ Res (1967) 5.05
Selection of successive tumour lines for metastasis. Nat New Biol (1973) 5.03
Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst (1970) 4.88
The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell (1994) 4.35
Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol (1991) 3.82
Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res (1991) 3.47
The dormant cancer cell. Br Med J (1954) 2.69
Metastatic inefficiency. Adv Cancer Res (1990) 2.40
Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis. Clin Exp Metastasis (1993) 1.73
Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev (1995) 1.66
Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metastasis (1994) 1.64
Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. Cancer Res (1995) 1.52
Evidence for the clonal origin of spontaneous metastases. Science (1982) 1.52
Relationship of host immune status to tumor cell arrest, distribution, and survival in experimental metastasis. Cancer (1977) 1.33
Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metastasis Rev (1995) 1.26
Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci U S A (1996) 1.25
The tumor dormant state. Adv Cancer Res (1981) 1.23
Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J (1994) 1.20
Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev (1993) 1.17
Intermittence of blood flow in liver sinusoids, studied by high-resolution in vivo microscopy. Am J Physiol (1995) 1.15
Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev (1982) 1.15
Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int J Cancer (1992) 1.06
Involvement of integrins in cell survival. Cancer Metastasis Rev (1995) 1.05
Macrophages in cancer metastases and their relevance to metastatic growth. Cancer Metastasis Rev (1983) 1.03
S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain. Acta Pathol Microbiol Immunol Scand A (1984) 1.00
Clonality of pulmonary metastases from the bladder 6 subline of the B16 melanoma studied by southern hybridization. J Natl Cancer Inst (1987) 0.98
Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes. Curr Opin Oncol (1991) 0.97
Use of NeoR B16F1 murine melanoma cells to assess clonality of experimental metastases in the immune-deficient chick embryo. Clin Exp Metastasis (1988) 0.96
Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells. Cancer Res (1994) 0.90
Microcirculatory changes in livers of mice infected with murine hepatitis virus. Evidence from microcorrosion casts and measurements of red cell velocity. Microvasc Res (1988) 0.86
Immunotherapy II: Antigens, receptors and costimulation. Cancer Metastasis Rev (1996) 0.85
Integration of the DNA of mouse mammary tumor virus in virus-infected normal and neoplastic tissue of the mouse. Cell (1979) 3.63
Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases. Lancet (1998) 2.75
Role of osteopontin in tumour progression. Br J Cancer (2004) 2.65
Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res (1993) 2.65
Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res (2000) 2.58
Comparison of mouse mammary tumor virus-specific DNA in inbred, wild and Asian mice, and in tumors and normal organs from inbred mice. J Mol Biol (1977) 2.45
Accidental hypothermia and impaired temperature homoeostasis in the elderly. Br Med J (1977) 2.42
Diagnosis of accidental hypothermia of the elderly. Lancet (1971) 2.41
Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene (1996) 2.13
Interhospital differences in severity of illness. Problems for prospective payment based on diagnosis-related groups (DRGs). N Engl J Med (1985) 2.00
CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res (1999) 1.82
Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res (2000) 1.74
Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis. Clin Exp Metastasis (1993) 1.73
Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res (1997) 1.71
Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev (1995) 1.66
Self-paced walking as a method for exercise testing in elderly and young men. Clin Sci Mol Med (1976) 1.65
Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer (1998) 1.64
Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metastasis (1994) 1.64
Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci (1999) 1.63
Psychiatric severity of illness. A case mix study. Med Care (1989) 1.62
Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. Cancer Res (1995) 1.52
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene (1999) 1.51
Osteopontin expression in lung cancer. Lung Cancer (1996) 1.51
Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am (2001) 1.48
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene (2006) 1.47
The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med (2001) 1.45
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Intracellular murine hepatitis virus-specific RNAs contain common sequences. Virology (1981) 1.39
Bacterial chromosomal restriction endonuclease analysis of the homology of Bacteroides species. J Clin Microbiol (1985) 1.39
Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67. Hum Pathol (1997) 1.33
Transcriptional promiscuity in testes. Curr Biol (1996) 1.31
Severity of illness within DRGs. Homogeneity study. Med Care (1986) 1.30
Solitary cancer cells as a possible source of tumour dormancy? Semin Cancer Biol (2001) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer (1996) 1.30
Geometrical distribution of capillaries in mammalian striated muscle. Am J Physiol (1975) 1.30
Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res (1994) 1.30
Clinical targets for anti-metastasis therapy. Adv Cancer Res (2000) 1.30
Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer (1998) 1.29
Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines. Clin Exp Metastasis (1993) 1.27
Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci U S A (1996) 1.25
Differences between genomes of two strains of mouse mammary tumor virus as shown by partial RNA sequence analysis. Virology (1976) 1.25
The role of osteopontin in breast cancer: clinical and experimental studies. J Mammary Gland Biol Neoplasia (2001) 1.24
Endogenous mouse mammary tumor virus DNA is distributed among multiple mouse chromosomes. Virology (1979) 1.24
Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). J Cell Biochem (2000) 1.24
Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res (1994) 1.23
Osteopontin and its receptor alphavbeta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab (2001) 1.23
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: enhanced expression in H-ras-transformed 3T3 cells. Biochem Biophys Res Commun (1988) 1.22
Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett (1997) 1.21
Characterization and chromosomal location of endogenous mouse mammary tumor virus loci in GR, NFS, and DBA mice. Virology (1984) 1.20
Capillary diameter and geometry in cardiac and skeletal muscle studied by means of corrosion casts. Microvasc Res (1983) 1.20
Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Int J Cancer (1990) 1.18
Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids (1995) 1.16
Intermittence of blood flow in liver sinusoids, studied by high-resolution in vivo microscopy. Am J Physiol (1995) 1.15
p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J Natl Cancer Inst (1994) 1.13
Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation. J Cell Biol (1991) 1.13
Some circulatory responses to haemorrhage in the cat: a critical level of blood volume for the onset of hypotension. Q J Exp Physiol Cogn Med Sci (1965) 1.12
Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms. J Cell Biochem (2000) 1.12
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Thermoregulation during marathon running in cool, moderate, and hot environments. J Appl Physiol (1975) 1.11